Keywords: European approval, Merck & Co, Cardiome, Brinavess, AstraZeneca, Seroquel, Major depressive, Law suits

European approval for Merck & Co/Cardiome’s IV Brinavess; added use for AstraZeneca’s Seroquel recommended

Article | 02 September 2010

Print This

US drug giant Merck & Co (NYSE; MRK) and Canada-based partner Cardiome Pharma (Nasdaq: CRME/TSX: COM) say that their ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in